Stock-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | 6 Months Ended |
Jun. 30, 2016 | Jun. 30, 2015 | Jun. 30, 2016 | Jun. 30, 2015 |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Stock-based compensation expense related to stock options, SAR and ESPP grants | | $ 13 | $ 11.7 | $ 26.2 | $ 23.3 |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | | | | | |
Common Shares Available for Grant | | 24,500,000 | | 24,500,000 | |
Compensation expense related to the company's stock-based compensation plans | | $ 27.1 | $ 28.6 | $ 59.5 | $ 61.7 |
Stock Options and SARs [Member] | | | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | $ 21.04 | $ 29.78 |
Expected Volatility (in hundredths) | | | | 35.90% | 38.93% |
Risk-Free Interest Rate (in hundredths) | | | | 0.93% | 0.82% |
Dividend Yield (in hundredths) | | | | 0.91% | 0.73% |
Expected Life (in years) | | | | 5 years 3 months 18 days | 5 years 3 months 18 days |
Stock Options and SARs Rollforward [Abstract] | | | | | |
Outstanding at January 1 (in shares) | | | | 10,744,000 | 10,493,000 |
Granted (in shares) | | | | 11,000 | 39,000 |
Exercised (1) (in shares) | [1] | | | (790,000) | (885,000) |
Forfeited (in shares) | | | | (150,000) | (177,000) |
Outstanding at June 30 (2) (in shares) | [2] | 9,815,000 | 9,470,000 | 9,815,000 | 9,470,000 |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | | | | | |
Outstanding at January 1 (price per share) | | | | $ 67.98 | $ 64.96 |
Granted (price per share) | | | | 71.51 | 92.37 |
Exercised (1) (price per share) | [1] | | | 44.31 | 48.30 |
Forfeited (price per share) | | | | 85.91 | 79.43 |
Outstanding at June 30 (2) (price per share) | [2] | $ 69.61 | $ 66.36 | $ 69.61 | $ 66.36 |
Stock Options and SARs Vested or Expected to Vest (in shares) | [3] | 9,490,000 | 8,987,000 | 9,490,000 | 8,987,000 |
Weighted average grant price for stock options/SARs vested or expected to vest (price per share) | [3] | $ 69.24 | $ 65.56 | $ 69.24 | $ 65.56 |
Stock Options and SARs Exercisable at June 30 (in shares) | [4] | 5,638,000 | 4,635,000 | 5,638,000 | 4,635,000 |
Stock Options and SARs Exercisable at June 30 (price per share) | [4] | $ 61.50 | $ 50.92 | $ 61.50 | $ 50.92 |
Unrecognized compensation expense | | $ 76 | | $ 76 | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 2 years 3 months 18 days | |
ESPP [Member] | | | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | $ 17.56 | $ 23.39 |
Expected Volatility (in hundredths) | | | | 36.79% | 37.47% |
Risk-Free Interest Rate (in hundredths) | | | | 0.49% | 0.11% |
Dividend Yield (in hundredths) | | | | 0.82% | 0.72% |
Expected Life (in years) | | | | 6 months | 6 months |
Restricted Stock And Restricted Stock Units [Member] | | | | | |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | | | | | |
Unrecognized compensation expense | | 137.8 | | $ 137.8 | |
Compensation expense related to the company's stock-based compensation plans | | $ 13.7 | $ 16.5 | $ 32.4 | $ 37.7 |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 2 years 3 months 18 days | |
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward] | | | | | |
Outstanding at January 1 (in shares) | | | | 4,908,000 | 5,394,000 |
Granted (in shares) | | | | 306,000 | 456,000 |
Released (1) (in shares) | [5] | | | (798,000) | (593,000) |
Forfeited (in shares) | | | | (203,000) | (130,000) |
Outstanding at June 30 (2) (in shares) | [6] | 4,213,000 | 5,127,000 | 4,213,000 | 5,127,000 |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward] | | | | | |
Outstanding at January 1 (price per share) | | | | $ 70.35 | $ 64.39 |
Granted (price per share) | | | | 75.56 | 88.29 |
Released (1) (price per share) | [5] | | | 61.36 | 54.85 |
Forfeited (price per share) | | | | 76.97 | 74.13 |
Outstanding at June 30 (2) (price per share) | [6] | $ 72.11 | $ 67.37 | $ 72.11 | $ 67.37 |
Performance Shares [Member] | | | | | |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | | | | | |
Unrecognized compensation expense | | $ 5.1 | | $ 5.1 | |
Compensation expense related to the company's stock-based compensation plans | | $ 0.4 | $ 0.4 | $ 0.9 | $ 0.7 |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 2 years 9 months 18 days | |
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward] | | | | | |
Outstanding at January 1 (in shares) | | | | 405,000 | |
Granted (in shares) | | | | 142,556 | |
Released (1) (in shares) | | | | (134,016) | |
Outstanding at June 30 (2) (in shares) | | 413,540 | | 413,540 | |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward] | | | | | |
Intrinsic value of stock and units released during the year | | | | $ 9.7 | |
Performance Units and Performance Stock [Abstract] | | | | | |
Minimum Performance Units and Stock Allowed to be Outstanding | | 151,096 | | 151,096 | |
Maximum Performance Units and Stock Allowed to be Outstanding | | 675,984 | | 675,984 | |
Maximum Vest Period from the Date of Grant | | | | 5 years | |
Performance Period for Performance units and shares | | | | 3 years | |
Minimum Performance Multiple at the Completion of the Performance Period | | | | 0.00% | |
Maximum Performance Multiple at the Completion of the Performance Period | | | | 200.00% | |
Lease And Well [Member] | | | | | |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | $ 8.9 | 10.5 | $ 19.3 | 22.6 |
Gathering And Processing Costs [Member] | | | | | |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 0.3 | 0.3 | 0.6 | 0.6 |
Exploration Costs [Member] | | | | | |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 5 | 5.9 | 11.5 | 13.3 |
General And Administrative [Member] | | | | | |
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | $ 12.9 | $ 11.9 | $ 28.1 | $ 25.2 |
| |
[1] | The total intrinsic value of stock options/SARs exercised for the six months ended June 30, 2016 and 2015 was $26.8 million and $39.1 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs. | |
[2] | The total intrinsic value of stock options/SARs outstanding at June 30, 2016 and 2015 was $173.1 million and $229.5 million, respectively. At June 30, 2016 and 2015, the weighted average remaining contractual life was 3.6 years and 3.9 years, respectively. | |
[3] | The total intrinsic value of stock options/SARs vested or expected to vest at June 30, 2016 and 2015 was $170.3 million and $223.6 million, respectively. At June 30, 2016 and 2015, the weighted average remaining contractual life was 3.6 years and 3.9 years, respectively. | |
[4] | The total intrinsic value of stock options/SARs exercisable at June 30, 2016 and 2015 was $137.7 million and $170.9 million, respectively. At June 30, 2016 and 2015, the weighted average remaining contractual life was 2.4 years and 2.6 years, respectively. | |
[5] | The total intrinsic value of restricted stock and restricted stock units released for the six months ended June 30, 2016 and 2015 was $60.8 million and $53.9 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released. | |
[6] | The total intrinsic value of restricted stock and restricted stock units outstanding at June 30, 2016 and 2015 was $351.5 million and $448.9 million, respectively. | |